Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies? M. TalaricoS. BarbatoK. Mancuso Case Report Open access 09 October 2025 Article: 288
“Life gives you a lemon, you make lemonade”: a qualitative study of identity among young male adult cancer survivors Glenn F. FlectherMay Aa. Hauken Research Open access 09 October 2025 Article: 287
The role of extracellular vesicles in the communication between endometrial cancer cells and tumour-associated macrophages: a review Feng LiWei Shi Review Open access 07 October 2025 Article: 286
Machine learning-based hepatocellular carcinoma risk prediction model for patients with HBV-related compensated advanced chronic liver disease Yanqiu LiZihang QiaoXianbo Wang Research Open access 07 October 2025 Article: 285
Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan Wen-Kuan HuangPo-Jung SuDong-Yi Chen Research Open access 07 October 2025 Article: 284
From pathogenesis to the patient’s bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma Piotr RemiszewskiSławomir FalkowskiAnna M. Czarnecka Review Open access 07 October 2025 Article: 283
Prognostic impact of lymph node count features in total laryngectomy for advanced laryngeal squamous cell carcinoma Mihnea Cristian TracheLisa BudelmannArne Böttcher Research Open access 07 October 2025 Article: 282
Transcriptional regulation of nucleotide metabolism in medulloblastoma subtypes and prognostic implications analyzed by RNA-Seq Rong HuangXiaoxu LuHui Wu Research Open access 07 October 2025 Article: 281
Deficient DNA mismatch repair and Nectin-4 expression in upper tract urothelial carcinoma (UTUC) Peichen DuanLe YuShudong Zhang Research Open access 07 October 2025 Article: 280
Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors Laurenz SperberMelanie von BrandensteinRichard Weiten Research Open access 07 October 2025 Article: 279
EYA1 promotes tumor angiogenesis in colorectal cancer by activating HIF-1β through LSD2-mediated H3K4me2 demethylation Shaoxin CaiJiansheng WuJinsi Wang Research Open access 04 October 2025 Article: 278
Mapping the global clinical landscape of NK cell therapies for solid tumors: an analysis based on the ClinicalTrials.gov for the 2005–2024 period Wenjuan WeiXimeng WuDaqing Wang Correspondence Open access 04 October 2025 Article: 277
tRF-34-86J8WPMN1E8Y2Q promotes the occurrence and development of gastric cancer by combining with LRAT Chunli CaoShengli XuZhe Li Research Open access 04 October 2025 Article: 276
Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study Maryann KwaGrant HusseySylvia Adams Research Open access 04 October 2025 Article: 275
Artificial neural networks as a prognostic tool using hyperspectral imaging on pretherapeutic histopathological specimens of esophageal adenocarcinoma Christel Teresa TrifoneMarianne MaktabiRené Thieme Research Open access 04 October 2025 Article: 274
Pellino ubiquitin ligases: double-edged swords in hematologic malignancies–from oncogenic stabilizers to therapeutic vulnerabilities Mingfeng YangYa LiJianhong Wang Review Open access 30 September 2025 Article: 273
Retrospective analysis of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia: focus on rechallenge with pegaspargase Chenhong JiaQian LiXiangyu Ding Review Open access 30 September 2025 Article: 272
Real-world evidence on the additional cancer risk reduction of ezetimibe: a 10-year nationwide retrospective cohort study emulating a target trial Yohwan LimEunji KimRyuk Jun Kwon Research Open access 29 September 2025 Article: 271
Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer Nurullah İlhanSüleyman BaşMahmut Gümüş Research Open access 27 September 2025 Article: 270
Casein kinase 1 family member CSNK1E can regulate proliferation and migration in hepatocellular carcinoma Jie ZhouYu-Hui WangLi-He Jiang Research Open access 27 September 2025 Article: 269
Prediction models for different types of leukemia: a systematic review and critical appraisal Yingzi YangAyizhati TuerxunShengfeng Wang Review Open access 27 September 2025 Article: 268
PDGFC facilitates enzalutamide resistance in prostate cancer through activation of the Rap1-MAPK pathway Bingqian DengSaipeng ChenGang Huang Research Open access 24 September 2025 Article: 267
Effect of gamma knife dose rate and tumor-specific factors on treatment outcomes in brain metastases: insights from a cohort study Onur ErdoğanAlaattin FidanBeste M. Atasoy Research Open access 24 September 2025 Article: 266
Advancements in the diagnosis and management of capecitabine-induced hand-foot syndrome Baohua ChenXingyu WangLingjun Meng Review Open access 22 September 2025 Article: 265
Low expression of HSP27 and HSP70 predicts poor prognosis in laryngeal squamous cell carcinoma Jędrzej BorowczakDariusz ŁaszczychMagdalena Bodnar Research Open access 19 September 2025 Article: 264
Advancing our understanding of the influence of myeloid-derived suppressor cells in chronic myeloid leukemia Xing MengYue ZhangXiaoyan Zhang Review Open access 19 September 2025 Article: 263
MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer Xu ChenRui KongJianguo Sun Research Open access 18 September 2025 Article: 262
Multimodal radiomics fusion for predicting postoperative recurrence in NSCLC patients Ghazal Mehri-kakavandSibusiso MdletsheAlan Wang Research Open access 18 September 2025 Article: 261
Correction: Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review Roberto RosenfeldStefano SgangaCiro Franzese Correction Open access 16 September 2025 Article: 260
PPARγ accelerates OSCC progression via Th17 polarization and CEBPA/IL-17C signaling Ying WangJing LiangXin Zeng Research Open access 16 September 2025 Article: 259
Development of a predictive model for distant metastasis in HCC patients post-TACE using clinical data, radiomics, and deep learning Chenglong LiuLong HanZhe Yang Research Open access 16 September 2025 Article: 258
Precision medicine in liver transplantation for hepatocellular carcinoma: applications and prospects of third-generation sequencing technology Ye TianXiaojuan WangQian Lu Review Open access 13 September 2025 Article: 257
FBXW11 inhibits tumorigenesis by ubiquitinating YB1 in hepatocarcinoma Wuguang LiuBin XuLiming Wang Research Open access 13 September 2025 Article: 256
Molecular signatures of breast cancer in the Iranian population: a review of cell growth and cell cycle regulators Zeynab MashayekhJalal Vallian BroojeniSadeq Vallian Review Open access 11 September 2025 Article: 255
The role of the transcription factor PATZ1 in tumorigenesis and metabolic regulation Yin ZhengJiabo ChenCheng Su Review Open access 11 September 2025 Article: 254
Clinical utility of comprehensive genomic profiling test for colorectal cancer: a single institution prospective observational study Hiroki TanabeKatsuyoshi AndoMikihiro Fujiya Research Open access 10 September 2025 Article: 253
The impact of miRNAs on epithelial–mesenchymal transition in lung cancer and the latest advances in their use as diagnostic markers Yilin ShiDongpeng ZhaoYan Gu Review Open access 10 September 2025 Article: 252
MRI-based radiomics signatures for predicting the efficacy of targeted therapy with lenvatinib in hepatocellular carcinoma: a retrospective cohort study Kun HuangHaiyan MaRongpin Wang Research Open access 10 September 2025 Article: 251
Assessing the catchment area of German comprehensive cancer centers by merging geographic healthcare data – an initiative of the ONCOnnect consortium A. KerscherM. Metzleron behalf of the ONCOnnect Consortium Correspondence Open access 10 September 2025 Article: 250
The evolution of targeted intra operative radiotherapy in early breast cancer Aparimita DasKhadeer AbdulkarimStergios Boussios Review Open access 10 September 2025 Article: 249
The imitation game: large language models versus multidisciplinary tumor boards: benchmarking AI against 21 sarcoma centers from the ring trial Cheng-Peng LiAimé Terence KalisaCui Yang Research Open access 10 September 2025 Article: 248
Dosimetry evaluation and uncertainty analysis of Cobalt-60 HDR brachytherapy for cervical cancer in resource-limited settings Asmaa M. El-DoushyEhab Marouf AttallaAyat M. Saadeldin Research Open access 09 September 2025 Article: 247
Retraction Note: Causal relationship between lung diseases and risk of esophageal cancer: insights from Mendelian randomization Jianfeng ZhouPinhao FangYong Yuan Retraction Note Open access 09 September 2025 Article: 246
Impact of sociodemographic and socioeconomic factors on functional and health-related quality of life outcomes 24 months after radical prostatectomy M. MaasK. FunkSteffen Rausch Research Open access 09 September 2025 Article: 245
DigiNet: Optimizing personalized care for patients with stage IV non-small cell lung cancer (NSCLC) through a digitally connected provider network–analysis plan of a prospective multicenter cohort trial Anika KästnerAnna KronWolfgang Hoffmann Research Open access 09 September 2025 Article: 244
Inhibition of dipeptidyl peptidase 9 improves sorafenib sensitivity by inducing ferroptosis in hepatocellular carcinoma Qing LiYang WangJun Zou Research Open access 09 September 2025 Article: 243
Expression patterns of plasma microRNAs in patients with cervical cancer from two teaching hospitals in Ghana Helena QuaysonJoseph Humphrey Kofi BonneyPrince Amoah Barnie Research Open access 05 September 2025 Article: 242
Comments on the SERAPHINA study assessing the utilization, efficacy, safety, and quality of life of nab-paclitaxel in patients with advanced HER2-negative breast cancer Kadri Altundag Matters Arising Open access 03 September 2025 Article: 241
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study. Simone RotaSilvia BuriollaCarlo Resteghini Research Open access 29 August 2025 Article: 240
Correlation of surgical volume in gynecological cancer centers with the quality of ovarian cancer care Olaf OrtmannRebecca RothSusanne Schüler-Toprak Research Open access 28 August 2025 Article: 239
